| Zacks Company Profile for Remedent, Inc. (REMI : OTC) |
|
|
| |
| • Company Description |
| Remedent Inc. researches, designs, develops, manufactures and distributes oral care and cosmetic dentistry products principally in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. Remedent Inc. is based in Ghent, Belgium.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.00 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 30,375 shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: -0.26 |
| 52 Week High: $0.06 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
50.00% |
46.07% |
| 12 Week |
-96.67% |
-96.81% |
| Year To Date |
-99.46% |
-99.52% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
BELGIUM ZUIDERLAAN 1-3 BUS 8
-
GHENT,C9 9000
BEL |
ph: 011-32-9241-5880
fax: 329-241-5899 |
None |
http://www.remedent.com |
|
|
| |
| • General Corporate Information |
Officers
De Vreese - Chairman and Chief Executive Officer
Philippe Van Acker - Chief Financial Officer and Chief Accounting Offic
Fred Kolsteeg - Director
Fred Kolsteeg - Director
- - -
|
|
Peer Information
Remedent, Inc. (ITRJ)
Remedent, Inc. (BRLI.)
Remedent, Inc. (GOGY)
Remedent, Inc. (PSTX.)
Remedent, Inc. (ELGXQ)
Remedent, Inc. (CAH)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 75954T104
SIC: 3843
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: -0.26
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
